Analysis and evaluation of the drug use on inpatients with cerebral infarction based on guideline and clinical pathway
10.13699/j.cnki.1001-6821.2014.07.022
- VernacularTitle:基于指南和临床路径的脑梗死住院患者用药分析与评价
- Author:
Na WANG
1
;
Rong-Sheng ZHAO
;
Lu-Lu SUN
;
Tong YU
Author Information
1. 北京大学第三医院药剂科
- Keywords:
cerebral infarction;
inpatients;
drug evaluation;
guideline;
clinical pathway
- From:
The Chinese Journal of Clinical Pharmacology
2014;(7):629-631
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze and evaluate the drug use on inpa-tients with cerebral infarction ( CI ).Methods By retrospective study method , the analysis of drug use on inpatients with CI , and evaluation of rationality of drug use based on the guidelines and clinical pathway of pa-tients with CI were carried out.Results Drugs or the treatment of CI accounted for 56.49%of all drugs ,and the top three are cerebrovascular medicine , anti-platelet agents and Chinese medicine preparations.Five types of national guidelines recommendations on CI drugs showed disa-greement,for example, insulin and anti-platelet agent etc.The national essential drugs for the treatment of CI in our hospital accounted for 40.27%, and the average cost of medicine was up to 10 000 yuan, accounting for about 50%of the total cost.84%of the medication was in accord with guidelines and clinical pathways.Conclusion The rationa-lity of some drugs for the treatment of CI lacks support from evidence -based medicine.
